MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • MassDevice Today
    • Cardiovascular
    • Clinical Trials
    • Legal News
    • Orthopedics
    • Regulatory/Compliance
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • More MedTech
    • Cosmetic/Aesthetic
    • Diabetes
    • Dialysis
    • Distribution
    • Imaging
    • Otolaryngology Ear, Nose & Throat
    • Pharma
    • Respiratory
    • Wound Care
  • Blog
  • DeviceTalks Podcasts
  • Resources
    • About MassDevice
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • White Papers
  • DeviceTalks
Home » ACC ’18 Roundup: Abbott releases long-term HeartMate 3 data

ACC ’18 Roundup: Abbott releases long-term HeartMate 3 data

March 12, 2018 By Sarah Faulkner Leave a Comment

Share

ACC '18Abbott (NYSE:ABT) touted two-year data yesterday from its trial designed to compare the company’s HeartMate 3 left ventricular assist device to its HeartMate 2 device in patients with advanced heart failure.

Data from the study were published in The New England Journal of Medicine and presented at the American College of Cardiology’s 67th Annual Scientific Session.

More than 1,000 patients participated in the study. Researchers assessed the trial’s participants for a short-term endpoint of six months and long-term endpoint of two years.

The two-year cohort met its primary endpoint, achieving 77.9% event-free survival – topping the 56.4% rate seen in patients treated with the HeartMate II LVAD.

Patients treated with the HeartMate 3 device had a survival rate of 82.8% after two years, compared to 76.2% for the HeartMate II group. Abbott also reported that low pump thrombosis rates remained low at 1.2% for the HeartMate 3 group, with no reoperations or pump replacements needed at two years.

Finally, the stroke rate in the HeartMate 2 group was 19% compared to just 10% for the patients treated with HeartMate 3.

“The long-term data for the pivotal Momentum 3 trial demonstrate overall survival of 83% at 2-years and marked improvement in clinical outcomes for our patients suffering with advanced heart failure,” Dr. Mandeep Mehra, medical director of Brigham and Women’s Hospital Heart and Vascular Center, said in prepared remarks. “We have seen greater pump durability—mostly driven by an absence of confirmed pump thrombosis—as well as a significantly lowered stroke rate without an increase in other adverse events.”

“As the leader in LVAD therapy, our goal is to provide patients with life-changing health technology that minimizes risk and offers them an enhanced quality of life. Data from the Momentum 3 study show Abbott’s significant progress in LVAD innovation and how it’s improving patient health outcomes,” Dr. John O’Connell, medical director for Abbott’s mechanical circulatory support business, added.

Abbott’s HeartMate 3 LVAD has CE Mark clearance in the E.U. and is approved by the FDA in the U.S. for short-term use. The company plans to use data from its Momentum 3 trial to support an regulatory bid for a long-term indication for HeartMate 3 in the U.S.

NEXT: Philips touts NEJM study on iFR v. FFR

With more than 30 speakers, 25 panels and 4 tracks, you can't miss DeviceTalks Minnesota

textadimage On June 4-5, DeviceTalks Minnesota is taking over the Twin Cities medtech industry with one of the most anticipated conferences of the spring.

Join leaders from 3M, Abbott, Bigfoot Biomedical, Boston Scientific, Cardionomic, CMF Solutions, Cyient, Google Mayo Clinic, Medical Alley, Medtronic, NxThera, Opus College, Relievant Medsystems, University of Minnesota, Star Tribune, Smith & Nephew, Spry Health, Zimmer Biomet and many more when you register today.

Use the code "DTWeb" to save 15% on the cost of registration. 

REGISTER TODAY

Pages: 1 2 3 4 5 6 7

Filed Under: Cardiac Assist Devices, Cardiac Implants, Cardiovascular, Clinical Trials, Diagnostics, Food & Drug Administration (FDA), Regulatory/Compliance, Research & Development, Vascular, Wall Street Beat Tagged With: Abbott, Aetna, AliveCor, iRhythm Technologies Inc., Janssen Pharmaceuticals, Medtronic, OrbusNeich, royalphilips, Scripps Research Institute, Zoll Medical Corp.

In case you missed it

  • Medineering touts first uses of Robotic Endoscopy system
  • Restech acquires Mederi Medical
  • ConMed shares rise on beat-and-raise Q1
  • InVivo Therapeutics registers $8m offering
  • Align Tech shares rise on Street-beating Q1, iTero CFDA win, product launches
  • V-Wave closes $70 million Series C
  • Cardiac Dimensions anchors $39m Series B for Carillon mitral repair device
  • Baxter beats The Street with Q1 results
  • Zimmer Biomet’s Q1 beats The Street despite profit slide
  • Novocure misses sales, EPS estimates in Q1
  • MicroPort Scientific buys Lombard Medical out of bankruptcy
  • Varian Medical Q2 beats The Street
  • Merit Medical Q1 earnings beat The Street, despite shrinking profits
  • Medin Technologies taps Donaldson as CEO | Personnel Moves – April 25, 2017
  • This is not your parents’ FDA
  • Natus Medical Q1 results beat The Street despite swing to red ink
  • How 3D printed cells on the skin could enable wound healing

RSS From Medical Design & Outsourcing

  • ProVerum Medical closes $4.2M investment round
    ProVerum Medical recently announced that it has closed a $4.2 million seed investment with Atlantic Bridge University Fund leading the investment round. Dublin-based ProVerum Medical, a startup company from Trinity College Dublin, received a number of investments from Irish and American angel investors like HBAN Medtech Syndicate, Irrus Investments, Boole and Xenium Capital. The $4.2 […]
  • Emerson launches new Branson welding workstations
    Emerson recently announced that it has launched its modular, custom engineered Branson welding workstations to help make the deployment of clean, secure and ergonomic production areas easier. The modular workstations are customizable and feature a height-adjustable, anodized-aluminum worktable and an ergonomic platform that weld-system operators can comfortably work on while standing or sitting. The worktable […]
  • How 3D printed cells on the skin could enable wound healing
    Researchers at the University of Minnesota are 3D printing electronics and cells directly on the skin that could create new methods for wound healing and enable biological agent detection. The Minnesota researchers used a customized, low-cost 3D printer to print electronics on a human hand. They’ve also successfully printed biological cells on a sin wound of […]
  • MW Industries acquires medical-component maker LaVezzi Precision
    MW Industries, a provider of highly engineered springs, specialty fasteners, machined parts, and other precision components, has acquired LaVezzi Precision Inc. — manufacturer of precision-machined components used by the medical-device industry. Located in Bloomingdale, Ill., LaVezzi was founded more than 100 years ago as a manufacturer of components for motion-picture projectors. The company reinvented itself in… […]
  • Razorleaf opens first international division
    Razorleaf (Stow, Ohio) announced that it has opened its first division outside of the U.S. in Northampton, U.K. The company’s new Razorleaf Europe will provide a single delivery and support service to customers in Europe. “We’ve already done projects in Europe, and have customers with both U.S. and European presence, but as we get into […]
  • MedAccred adds plastic extrusion to audit criteria
    MedAccred recently announced that it has added plastics extrusion to its list of audit opportunities. Companies that want accreditation from MedAccred can now audit plastics extrusion in addition to cable and harness, heat treating, plastics injection molding, printed circuit board assembly, sterilization and welding. The audit criteria is developed from leaders in the medical device […]
  • This augmented reality system projects medical images on the body
    Augmented reality is helping doctors visualize what’s inside the body without having to pick up a scalpel, thanks to a new system from the University of Alberta. The system ProjectDR projects medical images like CT scans and MRI data directly onto a patient’s body in a way that moves with the body. “We wanted to […]
  • What is a left ventricular assist device and how does it work?
    What is a left ventricular assist device? A left ventricle assist device (LVAD) is a mechanical pump that attaches to the left ventricle of the heart to supplement the function of the pumping chamber, according to Jodi Hutchins, a regulatory and quality consultant at Proven Process Medical Devices. The left ventricle of the heart is responsible […]
  • How video games could take market share from big pharma
    Tracy MacNeal, Ximedica At the Biotech Showcase in January, a panel discussed how video games are replacing drug therapies in a variety of diseases. If you haven’t seen the latest technology in this space, companies like Akili are providing drug-alternative therapies to kids with ADHD and Pear Therapeutics’ software is aimed at helping people with addiction. Technologists have reached incredible heights in getting people to […]
  • Tomorrow is Medical Alley Day in Minnesota
    Minnesota Gov. Mark Dayton has declared tomorrow as Medical Alley Day in the state — the same day the state’s Medical Alley Association is holding its annual meeting in downtown Minneapolis. The North Star State is one of three major medical device hubs in the U.S., the other two being California and Massachusetts. Dayton noted in his […]
  • Nelson Labs expands lab operations at Illinois facility
    Nelson Labs recently announced that it has invested in expanding its operations and service capabilities at its Itasca, Ill. facility. The investment will offer upgrades to the laboratory facilities, in addition to a 10,000 sq. ft building expansion and renovated lab space. The upgrades will include a BI sterility suite to support EO sterilization validations […]

Leave a Reply Cancel reply

You must be logged in to post a comment.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Privacy
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Connect with us on Google PlusGoogle+

Copyright © 2018 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy